Konrad H. Stopsack

3.7k total citations
83 papers, 1.6k citations indexed

About

Konrad H. Stopsack is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Konrad H. Stopsack has authored 83 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pulmonary and Respiratory Medicine, 30 papers in Cancer Research and 19 papers in Molecular Biology. Recurrent topics in Konrad H. Stopsack's work include Prostate Cancer Treatment and Research (40 papers), Cancer, Lipids, and Metabolism (23 papers) and Prostate Cancer Diagnosis and Treatment (15 papers). Konrad H. Stopsack is often cited by papers focused on Prostate Cancer Treatment and Research (40 papers), Cancer, Lipids, and Metabolism (23 papers) and Prostate Cancer Diagnosis and Treatment (15 papers). Konrad H. Stopsack collaborates with scholars based in United States, Sweden and Ireland. Konrad H. Stopsack's co-authors include Lorelei A. Mucci, Philip W. Kantoff, Emmanuel S. Antonarakis, Peter S. Nelson, Edward L. Giovannucci, Travis Gerke, Jennifer R. Rider, Michael J. Morris, Nikolaus Schultz and Wassim Abida and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Konrad H. Stopsack

73 papers receiving 1.6k citations

Peers

Konrad H. Stopsack
Chao Zhou China
José D. Debes United States
Young Oh Kweon South Korea
Pablo J. Cagnoni United States
Lorraine Pelosof United States
Chao Zhou China
Konrad H. Stopsack
Citations per year, relative to Konrad H. Stopsack Konrad H. Stopsack (= 1×) peers Chao Zhou

Countries citing papers authored by Konrad H. Stopsack

Since Specialization
Citations

This map shows the geographic impact of Konrad H. Stopsack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Konrad H. Stopsack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Konrad H. Stopsack more than expected).

Fields of papers citing papers by Konrad H. Stopsack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Konrad H. Stopsack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Konrad H. Stopsack. The network helps show where Konrad H. Stopsack may publish in the future.

Co-authorship network of co-authors of Konrad H. Stopsack

This figure shows the co-authorship network connecting the top 25 collaborators of Konrad H. Stopsack. A scholar is included among the top collaborators of Konrad H. Stopsack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Konrad H. Stopsack. Konrad H. Stopsack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Newton, Christina C., et al.. (2026). Leisure-Time Physical Activity and Cancer Mortality Among Cancer Survivors. JAMA Network Open. 9(2). e2556971–e2556971.
2.
Lis, Rosina T., Ying Huang, Emma H. Allott, et al.. (2025). Tumor Cholesterol Synthesis, Statin Use, and Lethal Prostate Cancer. Molecular Cancer Research. 23(12). 1025–1033.
3.
Rees‐Punia, Erika, Lauren R. Teras, Christina C. Newton, et al.. (2025). Leisure-time physical activity after diagnosis and survival by cancer type: a pooled analysis. JNCI Journal of the National Cancer Institute. 117(8). 1689–1698. 2 indexed citations
4.
Zhang, Yiwen, Konrad H. Stopsack, Adam S. Kibel, et al.. (2025). Identifying Patients at Risk of Early Lethal Prostate Cancer by Integrating Family History, Polygenic Risk Score, Rare Variants in DNA Repair Genes, and Lifestyle Factors. European Urology Oncology. 1 indexed citations
5.
Lee, Hwa‐Young, Minkyo Song, Konrad H. Stopsack, et al.. (2024). The Cancer Spectrum Theory. Cancer Discovery. 14(4). 589–593. 5 indexed citations
6.
Stopsack, Konrad H., Joseph Vijai, Jacob E. Berchuck, et al.. (2024). Germline DNA Damage Repair Variants and Prognosis of Patients with High-Risk or Metastatic Prostate Cancer. Clinical Cancer Research. 31(1). 122–129. 5 indexed citations
7.
Nandakumar, Subhiksha, Kalyani Chadalavada, Gwo-Shu Mary Lee, et al.. (2024). Quantifying Y chromosome loss in primary and metastatic prostate cancer by chromosome painting. PLoS ONE. 19(4). e0301989–e0301989. 1 indexed citations
8.
Stopsack, Konrad H., et al.. (2024). Social integration and long-term physical and psychosocial quality of life among prostate cancer survivors in the Health Professionals Follow-up Study. Journal of Cancer Survivorship. 20(1). 48–60. 2 indexed citations
9.
Iyer, Hari S., Kevin H. Kensler, Konrad H. Stopsack, et al.. (2023). Associations between Etiologic or Prognostic Tumor Tissue Markers and Neighborhood Contextual Factors in Male Health Professionals Diagnosed with Prostate Cancer. Cancer Epidemiology Biomarkers & Prevention. 32(8). 1120–1123. 3 indexed citations
10.
Ma, Chaoran, Xiaoyu Wang, James Y. Dai, et al.. (2023). Germline Genetic Variants Associated with Somatic TMPRSS2:ERG Fusion Status in Prostate Cancer: A Genome-Wide Association Study. Cancer Epidemiology Biomarkers & Prevention. 32(10). 1436–1443. 2 indexed citations
11.
Plym, Anna, Yiwen Zhang, Konrad H. Stopsack, et al.. (2022). Family History of Prostate and Breast Cancer Integrated with a Polygenic Risk Score Identifies Men at Highest Risk of Dying from Prostate Cancer before Age 75 Years. Clinical Cancer Research. 28(22). 4926–4933. 13 indexed citations
12.
Zhou, Charlie, Andreas Pettersson, Anna Plym, et al.. (2022). Differences in Prostate Cancer Transcriptomes by Age at Diagnosis: Are Primary Tumors from Older Men Inherently Different?. Cancer Prevention Research. 15(12). 815–825. 2 indexed citations
13.
Pan, Wenting, Zhouwei Zhang, Fangfang Qu, et al.. (2021). Abiraterone Acetate Induces CREB1 Phosphorylation and Enhances the Function of the CBP-p300 Complex, Leading to Resistance in Prostate Cancer Cells. Clinical Cancer Research. 27(7). 2087–2099. 24 indexed citations
14.
Stopsack, Konrad H., Subhiksha Nandakumar, Andreas G. Wibmer, et al.. (2020). Oncogenic Genomic Alterations, Clinical Phenotypes, and Outcomes in Metastatic Castration-Sensitive Prostate Cancer. Clinical Cancer Research. 26(13). 3230–3238. 119 indexed citations
15.
Stopsack, Konrad H., Ying Huang, Svitlana Tyekucheva, et al.. (2020). Multiplex Immunofluorescence in Formalin-Fixed Paraffin-Embedded Tumor Tissue to Identify Single-Cell–Level PI3K Pathway Activation. Clinical Cancer Research. 26(22). 5903–5913. 7 indexed citations
16.
Chakraborty, Goutam, Rahim Hirani, Subhiksha Nandakumar, et al.. (2020). Attenuation of SRC Kinase Activity Augments PARP Inhibitor–mediated Synthetic Lethality in BRCA2 -altered Prostate Tumors. Clinical Cancer Research. 27(6). 1792–1806. 17 indexed citations
17.
Allott, Emma H., Ericka M. Ebot, Konrad H. Stopsack, et al.. (2019). Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate Cancer. Clinical Cancer Research. 26(5). 1086–1093. 43 indexed citations
18.
Elfandy, Habiba, Joshua Armenia, Filippo Pederzoli, et al.. (2018). Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate. Molecular Cancer Research. 17(2). 446–456. 41 indexed citations
19.
Stopsack, Konrad H., Ericka M. Ebot, Mary K. Downer, et al.. (2018). Regular aspirin use and gene expression profiles in prostate cancer patients. Cancer Causes & Control. 29(8). 775–784. 1 indexed citations
20.
Stopsack, Konrad H., Travis Gerke, Jennifer A. Sinnott, et al.. (2016). Cholesterol Metabolism and Prostate Cancer Lethality. Cancer Research. 76(16). 4785–4790. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026